Search results
Germany’s Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions – Interview
The Wall Street Journal· 17 hours agoMerck—known as EMD Group in the U.S.— is betting on artificial-intelligence partnerships to develop...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 6 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Democrats ramp up patent fight with drug industry in bid to lower prices
Anchorage Daily News· 9 hours agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 days agoIn the first quarter, Wainua royalty revenues were $1 million. Wainua generated sales of $5 million...
BlackRock Favoring Growth Heading Into Second Half |
ETF Trends· 13 hours agoThe BlackRock Target Allocation Team, which runs model portfolios followed by many advisors, turned even more bullish this week.
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 4 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
Novel AI method could improve tissue and tumour analysis
Digital Journal· 8 hours agoThe technique is described as ‘Integrative and Reference-Informed tissue Segmentation’, or IRIS.
Veeva R&D Summit: Pharma companies need a say in AI regulation
Clinical Trials Arena via Yahoo Finance· 2 days agoSenderovitz is working with partners from other pharmaceutical companies, including James...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 2 days agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.
SGLT2s With Diuretics Improve Heart Failure Outcomes
Medscape· 1 day agoPatients with acute heart failure on the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin who received diuretic therapy experienced rapid...